# Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation

> **NCT03119584** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Texas Tech University Health Sciences Center, El Paso** · enrollment: 23 (actual)

## Conditions studied

- Chronic Constipation
- Diabete Mellitus

## Interventions

- **DRUG:** linaclotide or placebo

## Key facts

- **NCT ID:** NCT03119584
- **Lead sponsor:** Texas Tech University Health Sciences Center, El Paso
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-09-01
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119584, "Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03119584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*